Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT
Clinical trial NCT05983198 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05983198
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-07
- Primary completion
- 2031-03-04
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.